Clinical Trials Browser

Phase 2 × Terminated × alvocidib × Clear all

NCT02520011 2023-11-15

Alvocidib Biomarker-driven Phase 2 AML Study

Phase 2 Terminated

104 enrolled 12 charts

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT03969420 2023-11-09

Study of Alvocidib in Patients With Relapsed/Refractory AML Following Treatment With Venetoclax Combination Therapy

Phase 2 Terminated

11 enrolled 10 charts

Other hematologic neoplasm

Recurrence, Leukemia, Myeloid, Acute

NCT00098371 2016-10-24

Flavopiridol in Treating Patients With Chronic Lymphocytic Leukemia or Prolymphocytic Leukemia

Phase 2 Terminated

64 enrolled 16 charts

LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Prolymphocytic